MKI67 and non-small cell lung carcinoma: Despite these limitations, our systematic review of the literature showed that high expression of Ki-67 in NSCLC patients, particularly during the early stages (stages I–II), in Asians, and in ADC patients is a poor prognostic indicator for survival outcome.